Related Experiment Videos
Expression of recombinant Clostridium difficile toxin A using the Bacillus megaterium system
Silke Burger1, Helma Tatge, Fred Hofmann
1Institute of Toxicology, Hanover Medical School, Hanover, Germany. gerhard.ralf@mh-hannover.de
Biochemical and Biophysical Research Communications
|August 2, 2003
Summary
Researchers successfully expressed and purified recombinant toxin A from Clostridium difficile using the Bacillus megaterium system. This engineered toxin A demonstrated identical biological activity to the native toxin, paving the way for further research.
Area of Science:
- Microbiology
- Molecular Biology
- Biochemistry
Background:
- Pathogenic *Clostridium difficile* produces toxin A and toxin B, key virulence factors.
- Recombinant toxin A production is crucial for research and therapeutic development.
Purpose of the Study:
- To express and characterize recombinant toxin A using the *Bacillus megaterium* expression system.
- To generate a functional, His-tagged version of toxin A for purification and study.
Main Methods:
- A multi-part cloning strategy was employed to assemble the toxin A gene.
- The complete gene was ligated into the pWH1520 expression vector, modified for a C-terminal His-tag.
- Gene expression in *B. megaterium* yielded a ~300 kDa protein identified as toxin A.
- Purification utilized Ni(2+) and thyroglobulin affinity chromatography.
Main Results:
- Successful expression of a ~300 kDa recombinant toxin A protein.
- Purified recombinant toxin A exhibited identical cytotoxicity and *in vitro*-glucosyltransferase activity to native toxin A.
- The His-tag facilitated efficient purification via affinity chromatography.
Conclusions:
- The *Bacillus megaterium* expression system is effective for producing functional recombinant toxin A.
- Recombinant toxin A serves as a viable alternative to native toxin for research purposes.
- This work provides a foundation for developing novel diagnostics and therapeutics targeting *C. difficile*.